Clustering of ventricular tachyarrhythmias in heart failure patients implanted with a biventricular cardioverter defibrillator

Journal of Cardiovascular Electrophysiology

Volumn 17, Issue 12, 2006, Pages 1299-1306

  Lunati, Maurizio ^a   Gasparini, Maurizio ^b   Bocchiardo, Mario ^c   Curnis, Antonio ^d   Landolina, Maurizio ^e   Carboni, Angelo ^f   Luzzi, Gianni ^g   Zanotto, Gabriele ^h   Ravazzi, Pierantonio ⁱ   Magenta, Giovanni ^a   Denaro, Alessandra ^j   Distefano, Paola ^j   Grammatico, Andrea ^j  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c Civil Hospital   (Italy)

^d SPEDALI CIVILI   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f Maggiore Hospital   (Italy)

^g POLICLINICO   (Italy)

^h Civile Maggiore Hospital   (Italy)

ⁱ C Arrigo Children's Hospital   (Italy)

^j Clinical Department   (Italy)

more..

Author keywords

Defibrillation; Ischemic and nonischemic heart failure etiology; Primary and secondary prevention; Ventricular tachyarrhythmia clusters

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIMARY PREVENTION; PRIORITY JOURNAL; QRS COMPLEX; RECURRENCE RISK; SECONDARY PREVENTION; SUDDEN DEATH; TREATMENT INDICATION;

AGED; CLUSTER ANALYSIS; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; ITALY; MALE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR;

EID: 33751330178     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00618.x     Document Type: Article

References (41)

1. The Antiarrhythmics versus Implantable Defibrillator (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B, for the CIDS Investigators. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
3. Kuck KH, Cappato R, Siebels J, Ruppel F, for the CASH Investigators: Randomized comparison of antiarrhythmia drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-754.
4. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Moonseong H, for the Multicenter Automatic Defibrillator Implantation Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1993-1940.
5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G, for the Multicenter Unsustained Tachycardia Trial Investigators: A randomized study of the prevention of sudden death among patients with coronary artery disease. N Engl J Med 1999;341:1882-1890.
6. Moss AJ, Fadl Y, Zareba W, Cannom DS, Hall WJ, for the Multicenter Automatic Defibrillator Implantation Trial Research Group: Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary artery disease. Am J Cardiol 2001;88:516-520.
7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
8. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, DeMarco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM: Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
9. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
10. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ: Appropriate and inappropriate ventricular therapies, quality of life and mortality among primary and secondary prevention implantable cardioverter defibrillator patients. Circulation 2005;111:2898-2905.
11. Wilkoff BL, Hess M, Young J, Abraham WT: Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 2004;15:1002-1009.
12. Gasparini M, Lunati M, Bocchiardo M, Mantica M, Gronda E, Frigerio M, Caponi D, Carboni A, Boriani G, Zanotto G, Ravazzi PA, Curnis A, Puglisi A, Klersy C, Vicini I, Cavaglia S: Cardiac resynchronization and implantable cardioverter defibrillator therapy: Preliminary results from the InSync implantable cardioverter defibrillator italian registry. Pacing Clin Electrophysiol 2003;26:(Pt II):148-151.
13. Wood MA, Simpson PM, Stambler BS, Herre JM, Bernstein RC, Ellenbogen KA: Long-term temporal patterns of ventricular tachyarrhythmias. Circulation 1995;91:2371-2377.
14. Wood MA, Ellenbogen KA, Liebovitch LS: Electrical storms in patients with transvenous implantable cardioverter-defibrillators. J Am Coll Cardiol 1999;34:950-951.
15. Dorian P, Borggrefe M, Al-Khalidi HR, Hohnloser SH, Brum JM, Tatla DS, Brachmann J, Myerburg RJ, Cannom DS, van der Laan M, Holroyde MJ, Singer I, Pratt CM: Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 2004;110:3646-3654.
16. Stuber T, Eigenmann C, Delacretaz E: Characteristics and relevance of clustering ventricular arrhythmias in defibrillator recipients. PACE 2005;28:702-707.
17. Villacastin J, Almendral J, Arenal A Albertos J, Ormaetxe J, Peinado R, Bueno H, Merino JL, Pastor A, Medina O, Tercedor L, Jimenez F, Delcan JL: Incidence and clinical significance of multiple consecutive, appropriate, high energy discharges in patients with implanted cardioverter-defibrillators. Circulation 1996;93:753-762.
18. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH: Electrical storm in patients with transvenous implantable cardioverter- defibrillators incidence, management and prognostic implications. J Am Coll Cardiol 1998;32:1909-1915.
19. Exner DV, Pinski SL, Wyse G, Renfroe EG, Follmann D, Gold M, Beckman KJ, Coromilas J, Lancaster S, Hallstrom AP: Electrical storm presages nonsudden death the antiarrhythmics versus implantable de-fibrillators (AVID) trial. Circulation 2001;103:2066-2071.
20. Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP: Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol 2004;43:2293-2299.
21. Verma A, Kilicaslan F, Marrouche NF, Minor S, Khan M, Wazni O, Burkhardt JD, Belden WA, Cummings JE, Abdul-Kharim A, Saliba W, Schweikert RA, Tchou PJ, Martin DO, Natale A: Prevalence, predictors and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 2004;15:1265-1270.
22. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RJ, Antman EM, Alpert JS, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC: ACC ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-2161.
23. Ricci R, Ansalone G, Toscano S, Pignalberi C, Lunati M, Gasparini M, Padelketti L, Disertori M, Ravazzi PA, Santini M: Cardiac resynchronization: Materials, technique and results. The InSync Italian Registry. Eur Heart J 2000;2:J6-J15.
24. Hurwitz JL, Hook BG, Flores BT, Marchlinski FE: Importance of abortive shock capability with electrogram storage cardioverter-defibrillator devices. J Am Coll Cardiol 1993;21:895-900.
25. Hook BG, Callans DJ, Kleinman RB, Flores BT, Marchlinkski FE: Implantable cardioverter defibrillator therapy in the absence of significant symptoms. J Am Coll Cardiol 1993;21:895-900.
26. Leitch JW, Gillis AM, Wyse DG, Yee R, Klein GJ, Guiraudon G, Sheldon RS, Duff HJ, Kriser TM, Mitchell LB: Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy. J Am Coll Cardiol 1991;18:145-151.
27. Wang PJ, Mandalakas N, Clyne C, Butts L, Colburn C, Rostegar H, Estes MA: Accuracy of rhythm classification using a data log system in implantable cardioverter defibrillators. PACE Pacing Clin Electrophysiol 1991;14:1911-1916.
28. Roberts WC, Siegel RJ, Bm M: Idiopathic dilated cardiomyopathy: Analysis of 152 necropsy patients. Am J Cardiol 1987;60:1304-1315.
29. Delacretaz E, Stevenson WG, Ellison KE, Maisel WH, Friedman PL: Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol 2001;11:11-17.
30. Willich SN, Goldbert RJ, Maclure M, Perriello L, Muller JE: Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol 1992;70:65-68.
31. Francis GS: Interaction of the sympathetic nervous system and electrolytes in congestive heart failure. Am J Cardiol 1990;65:24E-27E.
32. Franz MR, Bargheer K, Raffenbeul W, Haverich A, Lichtten PR: Monophasic action potential mapping in human subjects with normal electrocardiograms: Direct evidence for the genesis of the T wave. Circulation 1987;75:379-386.
33. Smith ML, Ellenbogen KA, Beightol LA, Eckberg DL: Sympathetic neural responses to induced ventricular tachycardia. J Am Coll Cardiol 1991;18:1015-1024.
34. Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, Prystowsky EN: Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med 1999;340:1855-1862.
35. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH: Comparison of β-blockers, amiodarone plus β-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators. The OPTIC study: A randomized trial. JAMA 2006;295:165-171.
36. Stevenson WG, Friedman PL, Sweeney MO: Catheter ablation as an adjunct to ICD therapy. Circulation 1997;96:1378-1380.
37. Strickberger SA, Man KC, Daoud EG, Goyal R, Brinkman K, Hasse C, Bogun F, Knight BP, Weiss R, Bahu M, Morady F: A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator. Circulation 1997;96:1525-1531.
38. Soejima K, Stevenson WG: Catheter ablation of ventricular tachicardia in patients with ischemic heart disease. Curr Cardiol Rep 2003;5:364-368.
39. Silva RMFL, Mont L, Nava S, Rojel U, Matas M and Brugada J: Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defibrillator. PACE 2004;27:971-975.
40. Maggioni AP, Sinagra G, Opasich C, Geraci E, Gorini M, Gronda E, Lucci D, Tognoni G, Balli E, Tavazzi L: Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: The BRING-UP experience. Heart 2003;89:299-305.
41. Di Lenarda A, Scherillo M, Maggioni AP, Acquarone N, Ambrosio GB, Annicchiarico M, Bellis P, Bellotti P, De Maria R, Lavecchia R, Lucci D, Mathieu G, Opasich C, Porcu M, Tavazzi L, Cafiero M: Current presentation and management of heart failure in cardiology and internal medicine hospital units: A tale of two worlds-the TEMISTOCLE study. Am Heart J 2003;146:E12-E16.